Kidney and pancreas transplantation in the United States, 1998-2007: access for patients with diabetes and end-stage renal disease. Read more about Kidney and pancreas transplantation in the United States, 1998-2007: access for patients with diabetes and end-stage renal disease.
The clinical impact of an early decline in kidney function in patients following heart transplantation. Read more about The clinical impact of an early decline in kidney function in patients following heart transplantation.
Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort Study. Read more about Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort Study.
The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation. Read more about The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation.
A randomized, prospective trial of rituximab for acute rejection in pediatric renal transplantation. Read more about A randomized, prospective trial of rituximab for acute rejection in pediatric renal transplantation.
Liver transplantation for hepatocellular carcinoma: beyond the Milan criteria. Read more about Liver transplantation for hepatocellular carcinoma: beyond the Milan criteria.
Financial issues constraining the use of pancreata recovered for islet transplantation: a white paper. Read more about Financial issues constraining the use of pancreata recovered for islet transplantation: a white paper.
Organ donation and utilization in the United States, 1997-2006. Read more about Organ donation and utilization in the United States, 1997-2006.
HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Read more about HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes.
Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients. Read more about Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients.
